DKK1 and cancer: To summarize, DKK1 had immunoregulatory effects, including promoting Th2 cells response, reducing the functionality of T cells through MDSC modulation and suppressing the proliferation of CD8+ T cells and NK cells, thus contributing to inflammatory response and cancer immune evasion.